AI-Powered Chronic Heart Failure Digital Coach Market Report 2026

The artificial intelligence (AI)-powered chronic heart failure digital coach market size has grown exponentially in recent years. It will grow from $1.93 billion in 2025 to $2.48 billion in 2026 at a compound annual growth rate (CAGR) of 28.3%. The growth in the historic period can be attributed to increasing incidence of heart failure, expansion of remote patient monitoring adoption, rising healthcare digitization, growing availability of connected medical devices, increasing focus on preventive cardiac care.

The artificial intelligence (AI)-powered chronic heart failure digital coach market size is expected to see exponential growth in the next few years. It will grow to $6.64 billion in 2030 at a compound annual growth rate (CAGR) of 28%. The growth in the forecast period can be attributed to advancements in ai-powered clinical analytics, growing adoption of personalized care management, expansion of home-based cardiac monitoring, rising investments in digital cardiology platforms, increasing demand for continuous patient engagement solutions. Major trends in the forecast period include increasing deployment of AI-based cardiac monitoring coaches, growing integration with wearable heart sensors, rising use of predictive health analytics, expansion of remote chronic care platforms, enhanced focus on patient self-management tools.

The rising burden of cardiovascular diseases is expected to drive the growth of the artificial intelligence (AI)-powered chronic heart failure digital coach market in the coming years. Cardiovascular diseases include a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease, and other circulatory system conditions. The prevalence of cardiovascular diseases is increasing due to diets high in processed foods and salt, which elevate blood pressure and cholesterol and increase the risk of heart disease. AI-powered chronic heart failure digital coaches support cardiovascular disease management by continuously monitoring patient health, providing personalized guidance on medications and lifestyle, and enabling early detection of complications for proactive care. For example, in October 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that 919,032 people in the United States died from cardiovascular disease in 2023, accounting for approximately one in every three deaths nationwide. Consequently, the rising burden of cardiovascular diseases is fueling the growth of the AI-powered chronic heart failure digital coach market.

Key companies in the AI-powered chronic heart failure digital coach market are developing at-home monitoring solutions, such as non-invasive heart failure management platforms, to improve medication adherence and enable proactive disease management. These platforms track heart function and patient vitals without surgery, using sensors, wearables, and AI analytics to monitor symptoms and guide therapy for early intervention and better disease outcomes. For instance, in September 2024, Astellas Pharma Inc., a Japan-based pharmaceutical company, launched DIGITIVA, a non-invasive digital health solution for heart failure management, listed with the FDA. The platform enables at-home disease monitoring and places patients at the center of care, combining the CORE 500 Digital Stethoscope, a smartphone app built on Welldoc's platform, educational content from the American Heart Association, and a dedicated clinical review team to support early intervention and improve outcomes, such as reducing acute events and hospitalizations.

In September 2025, Innovaccer, a US-based digital healthcare company, acquired Story Health for an undisclosed amount. Through this acquisition, Innovaccer gains access to Story Health’s virtual care platform, remote patient monitoring infrastructure, and care-team engagement expertise, enhancing its personalized digital care capabilities while expanding operational scale and service reach. Story Health is a US-based digital health company that leverages AI to transform chronic heart failure management through its AI-powered platform.

Major companies operating in the artificial intelligence (AI)-powered chronic heart failure digital coach market are Koninklijke Philips N.V., Boston Scientific Corporation, Astellas Pharma Inc., Best Buy Health Inc., Tempus AI Inc., Biofourmis Inc., Athelas Inc., Hello Heart Inc., Huma Therapeutics Limited, Welldoc Inc., Cleerly Inc., Cadence Solutions Inc., Lark Health Inc., One Drop, Binah.ai Ltd., Xealth Inc., Nanowear Inc., Cordio Medical Ltd., Kento Health Inc., my mhealth Limited, Implicity SAS.

North America was the largest region in the artificial intelligence (AI)-powered chronic heart failure digital coach market in 2025. The regions covered in the artificial intelligence (AI)-powered chronic heart failure digital coach market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI)-powered chronic heart failure digital coach market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the ai-powered chronic heart failure digital coach market by increasing costs of imported wearable devices, biosensors, edge computing hardware, and data processing infrastructure. Healthcare providers in North America and Europe are most affected due to reliance on imported connected health devices, while Asia-Pacific faces cost pressure on manufacturing and device distribution. These tariffs are raising solution deployment costs and slowing device upgrades. However, they are also driving software-led innovation, local device assembly, and increased focus on cloud-native digital coaching platforms that reduce hardware intensity.

The artificial intelligence (AI)-powered chronic heart failure digital coach market research report is one of a series of new reports that provides artificial intelligence (AI)-powered chronic heart failure digital coach market statistics, including artificial intelligence (AI)-powered chronic heart failure digital coach industry global market size, regional shares, competitors with a artificial intelligence (AI)-powered chronic heart failure digital coach market share, detailed artificial intelligence (AI)-powered chronic heart failure digital coach market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered chronic heart failure digital coach industry. This artificial intelligence (AI)-powered chronic heart failure digital coach market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An artificial intelligence (AI)-powered chronic heart failure digital coach is a technology solution that provides real-time guidance and personalized insights to support the management of chronic heart failure. It continuously analyzes patient data to optimize health outcomes and encourage proactive care. The system enhances decision-making, improves adherence to care plans, and enables timely interventions, with an intelligent feedback loop that supports effective monitoring and self-management of heart health.

The main components of AI-powered chronic heart failure digital coaches include software, hardware, and services. Software consists of AI-driven applications that analyze patient data, deliver personalized recommendations, and enable remote monitoring and care management. These solutions are deployed via cloud-based and on-premises models and are applied in remote patient monitoring, personalized care management, medication adherence, patient education, and more. Key end-users include hospitals and clinics, homecare settings, research and academic institutes, and others.

The artificial intelligence (AI)-powered chronic heart failure digital coach market consists of revenues earned by entities by providing services such as data management services, clinical workflow optimization services, predictive analytics services, and patient engagement services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered chronic heart failure digital coach market also includes sales of digital health assistants, home monitoring equipment, smart sensors, and artificial intelligence (AI)-driven treatment recommendation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.